- Publications
- Search
- Statistics
AUGMENT: A Phase Iii Randomized Study of Lenalidomide Plus Rituximab (R-2) Vs Rituximab/Placebo in Patients with Relapsed/Refractory Indolent Non-Hodgkin Lymphoma
AuthID
P-00Q-938
P-00Q-938
21
Author(s)
Document Type
Abstract
Year published
2018
Published
in BLOOD, ISSN: 0006-4971
Volume: 132
Conference
60Th Annual Meeting of the American-Society-Of-Hematology (Ash), Date: DEC 01-04, 2018, Location: San Diego, CA, Sponsors: Amer Soc Hematol
Indexing
Publication Identifiers
Wos: WOS:000454837601154
Source Identifiers
ISSN: 0006-4971
Export Publication Metadata
Publication Export Settings
Marked List
Info
At this moment we don't have any links to full text documens.
Name Order | Name | Name Order | Name | Name Order | Name | ||
---|---|---|---|---|---|---|---|
1 | Leonard, JP; | 2 | Trneny, M; | 3 | Izutsu, K; | ||
4 | Fowler, NH; | 5 | Hong, XN; | 6 | Zhu, J; | ||
7 | Zhang, HL; | 8 | Offner, F; | 9 | Scheliga, A; | ||
10 | Nowakowski, GS; | 11 | Pinto, A; | 12 | Re, F; | ||
13 | Fogliatto, LM; | 14 | Scheinberg, P; | 15 | Flinn, IW; | ||
16 | Moreira, C; | 17 | Liu, D; | 18 | Kalambakas, S; | ||
19 | Fustier, P; | 20 | Wu, CQ; | 21 | Gribben, JG; |